Clinical efficacy of CT-guided 125I brachytherapy in patients with local residual or recurrent hepatocellular carcinoma after thermal ablation

Wenliang Zhu; Zhihui Zhong; Huzheng Yan; Huanqing Guo; Meigui Xiao; Xu He; Fei Gao; Fujun Zhang

doi:10.1186/s13244-022-01327-z

Insights into Imaging (Dec 2022)

Clinical efficacy of CT-guided 125I brachytherapy in patients with local residual or recurrent hepatocellular carcinoma after thermal ablation

Wenliang Zhu,
Zhihui Zhong,
Huzheng Yan,
Huanqing Guo,
Meigui Xiao,
Xu He,
Fei Gao,
Fujun Zhang

Affiliations

Wenliang Zhu: Department of Minimally Invasive and Interventional Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center
Zhihui Zhong: Department of Minimally Invasive and Interventional Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center
Huzheng Yan: Department of Interventional Radiology, The Third Affiliated Hospital, Sun Yat-Sen University
Huanqing Guo: Department of Minimally Invasive and Interventional Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center
Meigui Xiao: Department of Minimally Invasive and Interventional Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center
Xu He: ZhuHai Interventional Medical Center, ZhuHai People’s Hospital (ZhuHai Hospital Affiliated With Jinan University), Jinan University
Fei Gao: Department of Minimally Invasive and Interventional Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center
Fujun Zhang: Department of Minimally Invasive and Interventional Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center

DOI: https://doi.org/10.1186/s13244-022-01327-z
Journal volume & issue: Vol. 13, no. 1
pp. 1 – 9

Abstract

Read online

Key points 125I brachytherapy is a treatment for locally recurrent HCC after ablation. 125I brachytherapy combined with ablation may improve tumor control. Vascular invasion, multiple lesions, and AFP are prognostic risk factors. 125I brachytherapy is a safe method with a curative effect.

Published in Insights into Imaging

ISSN: 1869-4101 (Online)
Publisher: SpringerOpen
Country of publisher: Germany
LCC subjects: Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
Website: http://www.springer.com/13244

About the journal

Abstract

Keywords